The incidence of adenocarcinoma of the esophagogastric junction (AEG) continues to rise, with 20%-30% of patients initially diagnosed with stage IV disease, for whom conventional palliative treatment offers limited efficacy. Conversion therapy based on a multi... ...

请注册登录后继续浏览